Cargando…
Expression of concern: ‘Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial’
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423443/ https://www.ncbi.nlm.nih.gov/pubmed/37571965 http://dx.doi.org/10.1177/17534666231190750 |
| _version_ | 1785089452189679616 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10423443 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104234432023-08-14 Expression of concern: ‘Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial’ Ther Adv Respir Dis Expression of Concern SAGE Publications 2023-08-12 /pmc/articles/PMC10423443/ /pubmed/37571965 http://dx.doi.org/10.1177/17534666231190750 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Expression of Concern Expression of concern: ‘Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial’ |
| title | Expression of concern: ‘Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial’ |
| title_full | Expression of concern: ‘Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial’ |
| title_fullStr | Expression of concern: ‘Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial’ |
| title_full_unstemmed | Expression of concern: ‘Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial’ |
| title_short | Expression of concern: ‘Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial’ |
| title_sort | expression of concern: ‘two-day versus seven-day course of levofloxacin in acute copd exacerbation: a randomized controlled trial’ |
| topic | Expression of Concern |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423443/ https://www.ncbi.nlm.nih.gov/pubmed/37571965 http://dx.doi.org/10.1177/17534666231190750 |